AstraZeneca (www.AstraZeneca.com) is pleased to announce its partnership with the Pharmaceutical Society of Kenya (PSK) to launch the Kamba Ya Shanga initiative in Kenya, a pharmacy-led end-to-end digitally integrated patient solution for chronic disease management. The partnership forms part of their shared vision and commitment to work towards a future where all people have access to sustainable healthcare solutions for life-changing treatment.
The COVID-19 pandemic and the growing burden of non-communicable diseases (NCDs) have compelled healthcare stakeholders to explore new ways of improving health systems, stimulating the advancement of healthcare ecosystems that focus on securing continuum of care and improving treatment outcomes whilst also enhancing the patient experience.
The Kamba Ya Shanga initiative is a pharmacist-led disease management and referral programme aimed at improving patient outcomes for chronic conditions, connecting all key healthcare players along the patient’s disease management journey. Through the programme patients will be uniquely identified by the pharmacist, have their chronic disease treatment and medication monitored, receive support that ensures optimal treatment and correct use of devices; and be seamlessly referred by the Pharmacist to their General Practitioner should further consultation be required.
Dr. Daniella Munene, CEO of Pharmaceutical Society of Kenya (PSK) said: “Pharmacists are very uniquely positioned to expand reach of healthcare services by participating more in the management of chronic diseases. From detection of poorly managed or undiagnosed disease to providing medication therapy management and counselling, pharmacists can have a positive impact on therapeutic outcomes in patients on long-term medication for both communicable and non-communicable diseases.
Barbara Nel, AstraZeneca Country President for African Cluster (South Africa, Sub Sahara and French Speaking Africa) said: “At AstraZeneca we believe that patient experiences and outcomes are our shared responsibility, and that innovation doesn’t happen in isolation. Our Pharmacists play a critical role in the continuance of care for patients, especially in the current landscape. We are delighted to be partnering with PSK in the launch of Kamba Ya Shanga, which is a Swahili term that essentially means ‘a beautiful string of beads’. The string of beads represents the link between the patient, the pharmacist, and the doctor, transforming the ecosystem for patients, whilst enabling pharmacies to direct patients to a relevant healthcare professional and track their progress and response to medication.”
“By joining forces with PSK we look forward to making an even greater positive impact for patients and healthcare practitioners, achieving results that go beyond what any individual stakeholder can achieve. This is the value of partnerships, with the patient at the centre.”
Distributed by APO Group on behalf of AstraZeneca.About Pharmaceutical Society of Kenya (PSK):
The Pharmaceutical Society of Kenya (PSK) is the umbrella professional body for pharmacists that was formed to enable Pharmacists’ employ their professional expertise and safety in the care of patients. Since its formation, PSK continues to promote a common standard for professional conduct and code of ethics for its members, as well as advocate the welfare Pharmacists. Please visit www.PSK.or.ke.
About AstraZeneca:
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal&Metabolism, and Respiratory&Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit www.AstraZeneca.com and follow the Company on LinkedIn @AstraZeneca.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
